JOHN HOPE FRANKLIN CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Device: High Resolution Microendoscope
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Duke University
- Target Recruit Count
- 213
- Registration Number
- NCT00734838
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Safety and Efficacy on Cell-based Therapy in Patients With Recent Large Acute Myocardial Infarction
Phase 2
Withdrawn
- Conditions
- Acute Myocardial InfarctionHeart Failure
- Interventions
- Biological: Intracoronary delivery of unfractionated bone marrow mononuclear cellsBiological: Placebo
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2013-08-13
- Lead Sponsor
- Duke University
- Registration Number
- NCT00691834
Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation
Phase 2
Terminated
- Conditions
- Polycystic Ovarian Syndrome
- Interventions
- Dietary Supplement: flaxseed
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2012-11-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 4
- Registration Number
- NCT00693082
- Locations
- 🇺🇸
Duke Univeristy Medical Center, Durham, North Carolina, United States
Neuroimaging Attentional Impairment During Abstinence
Not Applicable
Completed
- Conditions
- Smoking
- Interventions
- Behavioral: Smoking Abstinence
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2013-03-28
- Lead Sponsor
- Duke University
- Target Recruit Count
- 80
- Registration Number
- NCT00692406
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease
Phase 1
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2008-05-08
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- Duke University
- Target Recruit Count
- 13
- Registration Number
- NCT00674791
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Correlation of Location of Abdominal Tenderness With Acute CT Abnormalities in Emergency Department Patients
Completed
- Conditions
- Abdominal Pain
- Interventions
- Device: radio-opaque adhesive skin markers
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2014-02-25
- Lead Sponsor
- Duke University
- Target Recruit Count
- 102
- Registration Number
- NCT00673374
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Pilot Trial of "Chemo-Switch" Regimen to Treat Advanced Melanoma
Phase 2
Terminated
- Conditions
- Melanoma
- Interventions
- Drug: Concurrent decrescendo biochemotherapy regimenDrug: Low-dose Temozolomide plus Sorafenib
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2016-01-13
- Lead Sponsor
- Duke University
- Target Recruit Count
- 9
- Registration Number
- NCT00673361
Early Detection of Lung Cancer Via Bi-plane Correlation Chest Imaging
Early Phase 1
Completed
- Conditions
- Metastatic Cancer in the LungsLung Cancer
- Interventions
- Device: bi-plane chest radiography
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2014-08-01
- Lead Sponsor
- Duke University
- Target Recruit Count
- 86
- Registration Number
- NCT00673283
- Locations
- 🇺🇸
Duke University Medcal Center, Durham, North Carolina, United States
Partnership for Glaucoma
Not Applicable
Completed
- Conditions
- Glaucoma
- Interventions
- Other: Computer TabletOther: Continuing educationOther: Continuing Education Course
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2014-01-06
- Lead Sponsor
- Duke University
- Target Recruit Count
- 721
- Registration Number
- NCT00672048
- Locations
- 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸University of Alabama, Birmingham, Alabama, United States
Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- Duke University
- Target Recruit Count
- 32
- Registration Number
- NCT00672243
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath